These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19751286)

  • 1. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
    Colaianni A; Cook-Deegan R
    Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Bayh-Dole Act March-In Rights to Lower US Drug Prices.
    Ouellette LL; Sampat BN
    JAMA Health Forum; 2024 Nov; 5(11):e243775. PubMed ID: 39485334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms.
    Sarpatwari A; Kesselheim AS; Cook-Deegan R
    J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act.
    Silva PJ; Ramos KS
    Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patents and innovation in cancer therapeutics: lessons from CellPro.
    Bar-Shalom A; Cook-Deegan R
    Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bayh-Dole Act turns 30.
    Loise V; Stevens AJ
    Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intellectual property. University licensing and the Bayh-Dole Act.
    Thursby JG; Thursby MC
    Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
    [No Abstract]   [Full Text] [Related]  

  • 9. Bayh-Dole: if we knew then what we know now.
    Boettiger S; Bennett AB
    Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
    [No Abstract]   [Full Text] [Related]  

  • 10. Lessons from Bayh-Dole.
    Sampat BN
    Nature; 2010 Dec; 468(7325):755-6. PubMed ID: 21150971
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent and license pearls and pitfalls for taking an idea to the marketplace.
    Mukharji I
    J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
    Berman EP
    Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology transfer at US universities: seeking public benefit from the results of basic research.
    Goodwin CD
    Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical technology transfer: the inventor's perspective.
    Marks LA
    Biomed Instrum Technol; 1991; 25(1):35-41. PubMed ID: 2004192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.
    Treasure CL; Avorn J; Kesselheim AS
    Milbank Q; 2015 Dec; 93(4):761-87. PubMed ID: 26626985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global biotech expansion taking cues from Bayh-Dole.
    Howard K
    Nat Biotechnol; 2004 Jul; 22(7):919-20. PubMed ID: 15259190
    [No Abstract]   [Full Text] [Related]  

  • 17. Patenting and licensing of university-based genetic inventions--a view from experience at Stanford University's Office of Technology Licensing.
    Leute K
    Community Genet; 2005; 8(4):217-22. PubMed ID: 16244475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intellectual property and biotechnology: the U.S. internal experience--Part I.
    Brody B
    Kennedy Inst Ethics J; 2006 Mar; 16(1):1-37. PubMed ID: 16770885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and the Bayh-Dole Act.
    Reczek PR
    Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412
    [No Abstract]   [Full Text] [Related]  

  • 20. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
    Mull WC
    Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.